HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development
Crossref DOI link: https://doi.org/10.1038/bjc.2014.388
Published Online: 2014-07-15
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, J C
Jhaveri, K
Esteva, F J
Text and Data Mining valid from 2014-07-15
Article History
Received: 20 February 2014
Revised: 11 June 2014
Accepted: 16 June 2014
First Online: 15 July 2014